マーケットレポート詳細

ポイントオブケア診断(PoC)：技術および世界市場2026年予測

Point of Care Diagnostics: Technologies and Global Markets

出版元：BCC Research 　 出版元について
発行年：2021年12月
定価 ：Single User License(1名様ライセンス)US$5,500(米国ドル)/　2-5 Users License $6,600/　Site License $7,920/　Enterprise License $9,504
ご予算に応じた各種ご提案も承ります。詳細はお問い合わせください。
ご請求は円換算（お見積り日TTSレート）となります。
納品形態：PDF by Email
当調査レポートは英文228ページになります。
商品コード：BCC346

お問い合わせ、お見積りのリクエストは下のボタンをクリックしてご入力ください。

【レポート紹介】

ポイントオブケア診断の世界市場規模は2021年で248億ドル、2026年に435億ドル、市場の平均年成長率は11.9%に達する見通しです。ポイントオブケア診断市場の促進要因の一つに感染症の有病率の上昇が挙げられます。POC診断は、特に医療インフラ不足のためにタイムリーな診断へのアクセスが困難な開発途上国において、感染症の管理を強化するのに役立ちます。
当レポートでは、ポイントオブケア診断の市場/技術的背景、市場ダイナミクス、COVID-19の影響、各種セグメント別市場分析(診断タイプ別、製品別、エンドユーザー別、国地域別)、競合状況、主要企業プロフィールなどを盛り込み、概略以下の構成でお届けいたします。

【レポート構成概要】

◆イントロダクション

・調査目的
・調査対象
・調査手法

◆サマリーと調査ハイライト

◆市場/技術的背景

・POCの新しいアプローチ
・米国におけるCLIAの重要性
・規制ガイドライン
・POC診断におけるFDAの役割
・結論

◆市場ダイナミクス

・ドライバー
・機会

◆COVID-19の影響

・MedTechへの影響
・COVID-19診断検査へのFDAの貢献

◆ポイントオブケア診断市場、診断タイプ別

・BGEM
・心臓マーカー
・コレステロール検査/モニタリング
・薬物/アルコールスクリーニング
・グルコース検査およびモニタリング
・感染症検査
・妊娠/出産検査
・ヘモグロビン/止血
・腫瘍マーカー
・尿検査/尿化学
・その他
※診断タイプ別に市場予測データ掲載（-2026）

◆ポイントオブケア診断市場、製品別

・ハードウェア
・ソフトウェア
※製品別に市場予測データ掲載（-2026）

◆ポイントオブケア診断市場、エンドユーザー別

・在宅ケア
・病院/救命救急

◆ポイントオブケア診断市場、国地域別

北米
・米国、カナダ
欧州
・ドイツ、英国、フランス
・イタリア、スペイン
・その他欧州
アジア太平洋
・日本、中国、インド
・その他アジア太平洋
その他地域
※地域別に全セグメント別の細分化データ掲載

◆競合状況

・企業シェア分析
・戦略
・地域のディストリビューター
・エンドユーザー
・最近の動向

◆ポイントオブケア診断の主要企業プロフィール

ABAXIS
ABBOTT
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES INC.
CARDINAL HEALTH
CHEMBIO DIAGNOSTICS
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
ELITECH GROUP
ESAOTE S.P.A.
GENERAL ELECTRIC
LIFESCAN
LUMOS DIAGNOSTICS HOLDINGS LTD.
MEDTRONIC PLC
MINDRAY MEDICAL INTERNATIONAL LTD.
NEXUS DX
NOVA BIOMEDICAL
ORASURE TECHNOLOGIES
PHILIPS HEALTHCARE
QUIDEL
ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.
ZOETIS INC.

(全228頁)


【レポート詳細目次、データ項目一覧は当ページ下を参照ください】

Table of Contents (英文詳細目次）

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
What's New in this Report?
Scope of Report
Defining POC Testing
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
BCC Custom Research
Related BCC Research Reports

Chapter 2 Summary and Highlights

Overview

Chapter 3 Market and Technology Background

Overview
Novel Approaches for POC

Significance of CLIA in the United States
Regulatory Guidelines
The FDA's Role in POC Testing

Conclusion

Chapter 4 Market Dynamics

Drivers

Opportunities

Chapter 5 COVID-19 Impact Analysis

Introduction
Impact on MedTech

FDA's Contribution to COVID-19 Diagnostic Testing

Chapter 6 Global Point of Care Diagnostics Market, by Test Type

BGEM

Cardiac Markers

Cholesterol Testing/Monitoring

Drug and Alcohol Screening

Glucose Testing and Monitoring

Infectious Disease Testing

Pregnancy and Fertility Testing

Hemoglobin and Hemostasis

Hemostasis (Coagulation)

Tumor Marker

Urinalysis/Urine Chemistry

Others

Chapter 7 Market Breakdown by Product

Hardware

Software

Chapter 8 Market Breakdown by End User

Home Care Settings

Hospitals and Critical Care Settings

Chapter 9 Market Breakdown by Region

Global Market for Point of Care Diagnostics by Region
North America

Europe

Asia-Pacific

Rest of the World (RoW)

Chapter 10 Competitive Landscape

Overview
Company Share Analysis
Strategies
Regional Distributors
End Users
Recent Developments

Chapter 11 Company Profiles

ABAXIS
ABBOTT
BECTON, DICKINSON AND CO.
BIO-RAD LABORATORIES INC.
CARDINAL HEALTH
CHEMBIO DIAGNOSTICS
DANAHER CORP.
EKF DIAGNOSTICS HOLDINGS PLC
ELITECH GROUP
ESAOTE S.P.A.
GENERAL ELECTRIC
LIFESCAN
LUMOS DIAGNOSTICS HOLDINGS LTD.
MEDTRONIC PLC
MINDRAY MEDICAL INTERNATIONAL LTD.
NEXUS DX
NOVA BIOMEDICAL
ORASURE TECHNOLOGIES
PHILIPS HEALTHCARE
QUIDEL
ROCHE HOLDING AG (F. HOFFMANN-LA ROCHE LTD.)
SIEMENS HEALTHCARE
THERMO FISHER SCIENTIFIC INC.
ZOETIS INC.

List of Tables

Summary Table : Global Market for Point of Care Diagnosis, by Region, Through 2026
Table 1 : Synonyms of POCT
Table 2 : Clinical Outcomes from Using Point of Care Testing
Table 3 : Commercial Systems for Near Patient Testing
Table 4 : Selected CLIA-Waived POC Tests
Table 5 : CLIA-Waived Tests Applications, by Test System/Manufacturers, 2018–October 2021
Table 6 : GMP Regulations Relevant Parameters Affecting In Vitro Diagnostics
Table 7 : Global HIV Data, 2000-2020
Table 8 : Global Estimated Number of New Cases of Curable STIs, 2019
Table 9 : Estimated Global Population and Annual Growth, by Selected Age Group and Selected Years, Through 2030
Table 10 : Global Geriatric Population (60 Years+), by Region, 2015-2050
Table 11 : Number of Deaths Due to COVID-19 Worldwide, by Country, as of Dec. 4, 2020
Table 12 : Leading Causes of Diseases around the World, 2004 and 2030
Table 13 : Global Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 14 : Global Market for BGEM, by Region, Through 2026
Table 15 : Global Deaths from CVD, 2015 and 2030
Table 16 : Global Market for Cardiac Markers, by Region, Through 2026
Table 17 : Global Market for Cholesterol Testing/Monitoring, by Region, Through 2026
Table 18 : Prevalence of Cannabis Use, by Region, 2019
Table 19 : Global Market for Drug and Alcohol Screening, by Region, Through 2026
Table 20 : Diabetes Patients by Region, 2019, 2030 and 2045
Table 21 : Global Market for Glucose Testing and Monitoring, by Region, Through 2026
Table 22 : Global Market for Infectious Disease Testing, by Region, Through 2026
Table 23 : Global Market for Pregnancy and Fertility Testing, by Region, Through 2026
Table 24 : Global Market for Hemoglobin and Hemostasis, by Region, Through 2026
Table 25 : Global Deaths from Cancer, 2015 and 2030
Table 26 : Global Market for Tumor Markers, by Region, Through 2026
Table 27 : Global Market for Urinalysis/Urine Chemistry, by Region, Through 2026
Table 28 : Global Market for Others, by Region, Through 2026
Table 29 : Global Market for Point of Care Diagnostics, by Product, Through 2026
Table 30 : Global Market for Hardware in Point of Care Diagnostics, by Region, Through 2026
Table 31 : Global Market for Software in Point of Care Diagnostics, by Region, Through 2026
Table 32 : Global Market for Point of Care Diagnostics, by End User, Through 2026
Table 33 : Global Market for Point of Care Diagnostics in Home Care Settings, by Region, Through 2026
Table 34 : Estimated Number of Hospitals Beds Available, by Country, 2018-2019
Table 35 : Estimated Nursing Homes Residents in U.S., by U.S. State, 2020
Table 36 : Number of Hospice Providers in America, by Type, in 2018
Table 37 : Global Market for Point of Care Diagnostics in Hospital and Critical Care End Use, by Region, Through 2026
Table 38 : Global Market for Point of Care Diagnostics, by Region, Through 2026
Table 39 : North American Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 40 : North American Market for Point of Care Diagnostics, by Product, Through 2026
Table 41 : North American Market for Point of Care Diagnostics, by End User, Through 2026
Table 42 : North American Market for Point of Care Diagnostics, by Country, Through 2026
Table 43 : COVID-19 Confirmed Cases and Deaths in the U.S., by State
Table 44 : STI Cases Across Canada, by Gender and Disease Type, 2018
Table 45 : European Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 46 : European Market for Point of Care Diagnostics, by Product, Through 2026
Table 47 : European Market for Point of Care Diagnostics, by End User, Through 2026
Table 48 : European Market for Point of Care Diagnostics, by Country, Through 2026
Table 49 : Geriatric Population in Germany, 2015-2030
Table 50 : Health Spending and Financing in France, 2005-2017
Table 51 : New Cancer Cases in Spain, by Type, 2020
Table 52 : Asia-Pacific Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 53 : Asia-Pacific Market for Point of Care Diagnostics, by Product, Through 2026
Table 54 : Asia-Pacific Market for Point of Care Diagnostics, by End User, Through 2026
Table 55 : Asia-Pacific Market for Point of Care Diagnostics, by Country, Through 2026
Table 56 : Japanese Market Statistics
Table 57 : Commonly Used POC Devices in the Indian Healthcare System.
Table 58 : Rest of the World Market for Point of Care Diagnostics, by Test Type, Through 2026
Table 59 : Rest of the World Market for Point of Care Diagnostics, by Product, Through 2026
Table 60 : Rest of the World Market for Point of Care Diagnostics, by End User, Through 2026
Table 61 : Middle East and North Africa HIV and AIDS Statistics, 2019
Table 62 : Recent Developments in Point of Care Diagnostics Market, 2019-2021
Table 63 : Abbaxis: Point of Care Diagnostic/Testing Products
Table 64 : Abbott: Financials, 2016-2020
Table 65 : Abbott: Product Portfolio, by Business Segment
Table 66 : Abbott: Point of Care Diagnostic Products
Table 67 : Abbott: Recent Developments, 2021
Table 68 : BD: Product Portfolio
Table 69 : BioRad Laboratories Product Portfolio
Table 70 : Cardinal Health Inc.: Product Portfolio
Table 71 : Chembio Diagnostics Inc.: Product Portfolio
Table 72 : Chembio Diagnostics: Recent Developments, 2021
Table 73 : Danaher Product Portfolio
Table 74 : EKF Diagnostics Holdings plc: Product Portfolio
Table 75 : ELITech Group: Product Portfolio
Table 76 : Esaote S.p.A.: Product Portfolio
Table 77 : GE: Financial Performance, 2019 and 2020
Table 78 : GE Healthcare: Point of Care Diagnostics Products
Table 79 : LifeScan Product Portfolio
Table 80 : Lumos Diagnostics Holdings Ltd.: Product Portfolio
Table 81 : Medtronic plc: Product Portfolio
Table 82 : Mindray Medical International Ltd.: Product Portfolio
Table 83 : Nexus DX: Product Portfolio
Table 84 : Nova Biomedical Product Portfolio
Table 85 : OraSure Technologies: Product Portfolio
Table 86 : Philips Healthcare: Product Portfolio
Table 87 : Quidel Corp.: Product Portfolio
Table 88 : F. Hoffmann-La Roche Ltd.: Financials, 2019
Table 89 : F. Hoffmann-La Roche Ltd.: Revenue, by Diagnostic Segment, 2016-2018
Table 90 : F. Hoffmann-La Roche Ltd.: Product Portfolio
Table 91 : F. Hoffmann-La Roche Ltd.: Recent Developments, 2021
Table 92 : Siemens Healthcare GmbH: Product Segments
Table 93 : Siemens Healthcare GmbH: Point of Care Diagnostics Products
Table 94 : Siemens Healthcare GmbH: Financials, 2019
Table 95 : Siemens Healthcare GmbH: Key Developments, 2020
Table 96 : Thermo Fisher Scientific: Product Portfolio
Table 97 : Thermo Fisher Scientific: Key Developments, 2021
Table 98 : Zoetis Inc. Product Portfolio

List of Figures

Summary Figure A : Global Market for Point of Care Diagnosis, by Region, 2019-2026
Summary Figure B : Global Market Shares of Point of Care Diagnosis, by Region, 2020
Figure 1 : Distribution of Malaria Cases, by Country, 2018
Figure 2 : Incidences of Diagnosed Infectious Disease, by Country, 2019
Figure 3 : Flow of Funding for Disease Research, 2014-2018
Figure 4 : Worldwide Funding in Tuberculosis Research and Development, by Institutions, 2019
Figure 5 : Estimated Global Population, by Selected Age Group and Selected Years, 2000-2030
Figure 6 : Global Population Age 60+, 2014-2022
Figure 7 : Trends in the Number of Deaths Due to Chronic Disease, 2005-2020
Figure 8 : Global Market Shares of Point of Care Diagnostics, by Test Type, 2020
Figure 9 : Global Market Shares of Point of Care Diagnostics, by Test Type, 2019-2026
Figure 10 : Number of People Aged 65 Years and Above, by Region, 2019 and 2050
Figure 11 : Global Market for BGEM, 2019-2026
Figure 12 : Global Market for BGEM, by Region, 2019-2026
Figure 13 : Global Deaths from CVD, 2015 and 2030
Figure 14 : Global Market for Cardiac Markers, 2019-2026
Figure 15 : Global Market for Cardiac Markers, by Region, 2019-2026
Figure 16 : Global Market for Cholesterol Testing/Monitoring, 2019-2026
Figure 17 : Global Market for Cholesterol Testing/Monitoring, by Region, 2019-2026
Figure 18 : Global Market for Drug and Alcohol Screening, 2019-2026
Figure 19 : Global Market for Drug and Alcohol Screening, by Region, 2019-2026
Figure 20 : Global Market for Glucose Testing and Monitoring, 2019-2026
Figure 21 : Global Market for Glucose Testing and Monitoring, by Region, 2019-2026
Figure 22 : Number of New HIV Infections in 2019, by Region
Figure 23 : Global Market for Infectious Disease Testing, 2019-2026
Figure 24 : Global Market for Infectious Disease Testing, by Region, 2019-2026
Figure 25 : Global Market for Pregnancy and Fertility Testing, 2019-2026
Figure 26 : Global Market for Pregnancy and Fertility Testing, by Region, 2019-2026
Figure 27 : Global Market for Hemoglobin and Hemostasis, 2019-2026
Figure 28 : Global Market for Hemoglobin and Hemostasis, by Region, 2019-2026
Figure 29 : Global Deaths from Cancer, 2015 and 2030
Figure 30 : Global Market for Tumor Markers, 2019-2026
Figure 31 : Global Market for Tumor Markers, by Region, 2019-2026
Figure 32 : Global Market for Urinalysis/Urine Chemistry, 2019-2026
Figure 33 : Global Market for Urinalysis/Urine Chemistry, by Region, 2019-2026
Figure 34 : Global Market for Others, 2019-2026
Figure 35 : Global Market for Others, by Region, 2019-2026
Figure 36 : Global Market Shares of Point of Care Diagnostics, by Product, 2020
Figure 37 : Global Market for Hardware in Point of Care Diagnostics, 2019-2026
Figure 38 : Global Market for Hardware in Point of Care Diagnostics, by Region, 2019-2026
Figure 39 : Global Market for Software in Point of Care Diagnostics, 2019-2026
Figure 40 : Global Market for Software in Point of Care Diagnostics, by Region, 2019-2026
Figure 41 : Global Market Shares of Point of Care Diagnostics, by End User, 2020
Figure 42 : Global Market for Point of Care Diagnostics in Home Care Settings, 2019-2026
Figure 43 : Global Market for Point of Care Diagnostics in Home Care Settings, by Region, 2019-2026
Figure 44 : Number of Operating Hospice Facilities in the U.S., 2014-2018
Figure 45 : Global Market for Point of Care Diagnostics in Hospital and Critical Care Centers, 2019-2026
Figure 46 : Global Market for Point of Care Diagnostics in Hospital and Critical Care Centers, by Region, 2019-2026
Figure 47 : Global Market for Point of Care Diagnostics, by Region, 2019-2026
Figure 48 : Global Market Shares of Point of Care Diagnostics, by Region, 2020
Figure 49 : North American Market Shares of Point of Care Diagnostics, by Country, 2020
Figure 50 : Venture Investment in Infectious Disease Companies Across U.S., 2006-2018
Figure 51 : The U.S. Market for Point of Care Diagnostics, 2019-2026
Figure 52 : Canadian Market for Point of Care Diagnostics, 2019-2026
Figure 53 : Geriatric Population in Germany, 2000-2030
Figure 54 : German Market for Point of Care Diagnostics, 2019-2026
Figure 55 : U.K. Market for Point of Care Diagnostics, 2019-2026
Figure 56 : Health Spending and Financing in France, 2005-2017
Figure 57 : French Market for Point of Care Diagnostics, 2019-2026
Figure 58 : Italian Market for Point of Care Diagnostics, 2019-2026
Figure 59 : Deaths Due to Infectious and Parasitic Diseases in Spain in 2018, by Age Group
Figure 60 : New Cancer Cases in Spain, by Type, 2020
Figure 61 : Spanish Market for Point of Care Diagnostics, 2019-2026
Figure 62 : Rest of the European Market for Point of Care Diagnostics, 2019-2026
Figure 63 : Allocation of Diagnosed Infectious Diseases in Selected Countries, by Gender, 2019
Figure 64 : Chinese Incidence of Infectious Diseases, by Type, 2019
Figure 65 : Chinese Incidence of STDs, by Type, 2019
Figure 66 : Chinese Market for Point of Care Diagnostics, 2019-2026
Figure 67 : Trends in Aging in Japan, 2010-2040
Figure 68 : Japanese Market for Point of Care Diagnostics, 2019-2026
Figure 69 : Limitations of Using POC Devices in India
Figure 70 : Indian Market for Point of Care Diagnostics, 2019-2026
Figure 71 : Rest of Asia-Pacific Market for Point of Care Diagnostics, 2019-2026
Figure 72 : Rest of the World Market for Point of Care Diagnostics, 2019-2026
Figure 73 : Global Manufacturer/Supplier Market Shares of Point of Care Diagnostics, 2020
Figure 74 : Strategies Adopted by Key Market Players
Figure 75 : Abbott: Revenue Share, by Region/Country, 2019
Figure 76 : Abbott: Revenue Share, by Business Segment, 2019
Figure 77 : BD: Annual Revenue, 2018-2020
Figure 78 : BD: Revenue Share, by Region, 2020
Figure 79 : BD: Revenue Share, by Business Segment, 2020
Figure 80 : Danaher Corp.: Annual Revenue, 2018-2020
Figure 81 : Danaher Corp.: Revenue Share, by Geography, 2020
Figure 82 : Danaher Corp.: Revenue Share, by Segment, 2020
Figure 83 : GE: Revenue Share, by Business Segment, 2020
Figure 84 : GE Healthcare: Revenue Share, by Region, 2020
Figure 85 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Segment, 2019
Figure 86 : F. Hoffmann-La Roche Ltd.: Revenue Share, by Region/Country, 2019
Figure 87 : Siemens Healthcare GmbH: Revenue Share, by Business Segment, 2019
Figure 88 : Siemens Healthcare GmbH: Revenue Share, by Region, 2019
Figure 89 : Thermo Fisher Scientific: Annual Revenue, 2019-2020
Figure 90 : Thermo Fisher Scientific: Revenue Share, by Region, 2020
Figure 91 : Thermo Fisher Scientific: Revenue Share, by Segment, 2020


△ 一番上に戻る